QSOX1 Inhibitors Development into a Clinically Applicable Anticancer Drug by Generating RCC Mouse Xenograft Models

Project: Research project

Project Details

Description

QSOX1 Inhibitors Development into a Clinically Applicable Anticancer Drug by Generating RCC Mouse Xenograft Models QSOX1 inhibitors development into a clinically applicable anticancer drug by generating RCC mouse xenograft models
StatusFinished
Effective start/end date8/2/159/15/16

Funding

  • Mayo Clinic Arizona: $41,127.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.